| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $638.50M | $385.69M | $270.60M | $0.00 | – |
| Cost of Revenue | – | – | – | $5.20M | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | $124.71M |
| R&D | $183.28M | $187.08M | $97.94M | $57.95M | $58.06M |
| SG&A | $570.60M | $411.36M | $323.12M | $159.25M | $66.65M |
| Operating Income | -$166.76M | -$280.56M | -$231.82M | -$179.80M | -$124.71M |
| Interest Expense | -$15.93M | -$21.58M | -$20.03M | -$9.66M | – |
| Tax Expense | -$530.00K | $85.00K | $960.00K | $0.00 | $0.00 |
| Net Income | -$183.17M | -$287.22M | -$239.24M | -$187.13M | -$130.40M |
| EPS (basic) | -3.6800 | -5.9900 | -5.2700 | -4.6000 | -3.4700 |
| EPS (diluted) | -3.6800 | -5.9900 | -5.2700 | -4.6000 | -3.4700 |
| Shares (diluted) | $49.75M | $47.91M | $45.43M | $40.66M | $37.62M |